Pancuroniumbromid Panpharma (Pancuronium Bromide)

Pancuronium bromide, the active ingredient in Pancuroniumbromid Panpharma, is a neuromuscular blocking agent presented as a sterile injectable for intravenous use. It provides skeletal muscle relaxation to facilitate endotracheal intubation and to support surgical procedures in adult patients.

GNH USA supplies Pancuroniumbromid Panpharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Pancuronium bromide is a non‑depolarizing neuromuscular blocker used in anesthesia and airway management.

- Facilitation of endotracheal intubation: produces rapid, profound muscle relaxation to allow safe tube placement. - Muscle relaxation during surgery: enables controlled skeletal muscle paralysis for operative conditions. - Adjunct to general anesthesia: maintains muscle relaxation throughout the anesthetic period.

Pancuronium bromide may be associated with a range of adverse reactions, which are categorized by frequency.

Common Side Effects: - Tachycardia: increased heart rate due to vagolytic activity. - Hypertension: elevation of arterial blood pressure. - Flushing: transient skin reddening. - Increased salivation: excess oral secretions. - Bronchospasm: narrowing of airway smooth muscle.

Serious or Rare Side Effects: - Prolonged paralysis: extended duration of muscle block requiring mechanical ventilation. - Anaphylaxis: severe allergic reaction with hypotension and airway compromise. - Malignant hyperthermia: hypermetabolic crisis in susceptible individuals. - Respiratory arrest: cessation of breathing if ventilation is not maintained. - Cardiac arrhythmias: irregular heart rhythms, especially in patients with pre‑existing cardiac disease.

When using Pancuronium bromide, clinicians should observe specific safety measures.

- Cardiac disease: monitor heart rate and blood pressure closely. - Neuromuscular disorders: avoid or use reduced doses in patients with myasthenia gravis or Eaton‑Lambert syndrome. - Electrolyte imbalance: correct hyperkalemia before administration. - Concomitant muscle relaxants: avoid additive neuromuscular blockade. - Pregnancy: safety not established; use only if benefit outweighs risk. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Pancuronium bromide can interact with several drug classes, influencing the depth and duration of neuromuscular blockade.

Major Interactions (Avoid): - Aminoglycoside antibiotics: potentiate blockade and may cause prolonged paralysis. - Succinylcholine: additive neuromuscular blockade leading to severe muscle weakness. - Magnesium sulfate: enhances the effect and can result in unexpected prolonged block.

Moderate Interactions (Monitor Closely): - Volatile anesthetics (e.g., sevoflurane, isoflurane): increase potency of pancuronium. - Calcium channel blockers: may modestly prolong neuromuscular blockade. - Beta‑adrenergic antagonists: can affect heart rate response during blockade.